WallStreetZenWallStreetZen

NASDAQ: IMDX
Insight Molecular Diagnostics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IMDX

Based on 3 analysts offering 12 month price targets for Insight Molecular Diagnostics Inc

Min Forecast
$4.00-5.66%
Avg Forecast
$5.42+27.76%
Max Forecast
$8.00+88.68%

Should I buy or sell IMDX stock?

Based on 3 analysts offering ratings for Insight Molecular Diagnostics Inc.

Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IMDX stock forecasts and price targets.

IMDX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-21
lockedlocked$00.00+00.00%2025-05-13
lockedlocked$00.00+00.00%2025-03-26

1 of 1

Forecast return on equity

Is IMDX forecast to generate an efficient return?

Company
-229.51%
Industry
-0.84%
Market
47.37%
IMDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMDX forecast to generate an efficient return on assets?

Company
-38.85%
Industry
8.94%
IMDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMDX earnings per share forecast

What is IMDX's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.82

IMDX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
IMDX$4.24$5.42+27.76%Buy
PRE$8.96$9.00+0.45%Strong Buy
XGN$7.23$7.50+3.73%Strong Buy
VNRX$0.92$3.50+280.43%Strong Buy
FONR$14.18N/AN/A
View Top Diagnostic & Research Stocks

Insight Molecular Diagnostics Stock Forecast FAQ

Is Insight Molecular Diagnostics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: IMDX) stock is to Buy IMDX stock.

Out of 3 analysts, 1 (33.33%) are recommending IMDX as a Strong Buy, 1 (33.33%) are recommending IMDX as a Buy, 1 (33.33%) are recommending IMDX as a Hold, 0 (0%) are recommending IMDX as a Sell, and 0 (0%) are recommending IMDX as a Strong Sell.

If you're new to stock investing, here's how to buy Insight Molecular Diagnostics stock.

What is IMDX's earnings growth forecast for 2025-2025?

(NASDAQ: IMDX) Insight Molecular Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Insight Molecular Diagnostics's earnings in 2025 is -$58,262,000.

In 2025, IMDX is forecast to generate -$23,451,414 in earnings, with the lowest earnings forecast at -$23,451,414 and the highest earnings forecast at -$23,451,414.

What is IMDX's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: IMDX) forecast ROE is -229.51%, which is considered weak.

What is IMDX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year IMDX price target, the average IMDX price target is $5.42, with the highest IMDX stock price forecast at $8.00 and the lowest IMDX stock price forecast at $4.00.

On average, Wall Street analysts predict that Insight Molecular Diagnostics's share price could reach $5.42 by May 21, 2026. The average Insight Molecular Diagnostics stock price prediction forecasts a potential upside of 27.76% from the current IMDX share price of $4.24.

What is IMDX's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: IMDX) Insight Molecular Diagnostics's current Earnings Per Share (EPS) is -$3.90. In 2025, IMDX's EPS is forecast to hit -$0.82 (min: -$0.82, max: -$0.82).

What is IMDX's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: IMDX) forecast ROA is -38.85%, which is lower than the forecast US Diagnostics & Research industry average of 8.94%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.